Reaction
Incorrect Disposal Of Product reporting signals
As of the last recalculation, Incorrect Disposal Of Product appears in 3,163 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is EVOLOCUMAB (PRR 144.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Evolocumab | 1,683 | 144.8 | 146.3 |
| Erenumab-Aooe | 453 | 63.0 | 63.5 |
| Pegfilgrastim | 359 | 26.9 | 27.0 |
| Belimumab | 29 | 6.1 | 6.1 |
| Rimegepant Sulfate | 6 | 3.1 | 3.1 |
| Etanercept | 245 | 2.8 | 2.8 |
| Guselkumab | 15 | 2.8 | 2.8 |
| Benralizumab | 7 | 2.3 | 2.3 |
| Romosozumab-Aqqg | 3 | 1.5 | 1.5 |